Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B

Journal of Medical Virology

Volumn 78, Issue 10, 2006, Pages 1284-1288

  Moutinho, Renata S ^a   Perez, Renata M ^b   Medina Pestana, José O ^a   Figueiredo, Mauro S ^c   Koide, Sandra ^c   Alberto, Fernando Lopes ^c   Silva, Antonio Eduardo B ^a   Ferraz, Maria Lucia G ^a,d  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Fleury   (Brazil)

^d NONE   (Brazil)

Author keywords

HBeAg negative; Hemodialysis; Hepatitis B; Precore mutation; Viral load

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; FEMALE; HEMODIALYSIS; HEPATITIS B; HEPATITIS C VIRUS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SUPERINFECTION; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION;

ADULT; BIOLOGICAL MARKERS; CARRIER STATE; CODON; DNA, VIRAL; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; RENAL DIALYSIS; VIRAL LOAD;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 33748665953     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20691     Document Type: Article

References (38)

1. Booth JC, Goldin RD, Brown JL, Karayiannis P, Thomas HC. 1995. Fibrosing cholestatic hepatitis in a renal transplant recipient associated with the hepatitis B virus precore mutant. J Hepatol 22:500-503.
2. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC. 1989. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 2:588-591.
3. Cohen G, Haag-Weber M, Horl WH. 1997. Immune dysfunction in uremia. Kidney Int Suppl 62:879-882.
4. Conjeevaram HS, Lok AS. 2003. Management of chronic hepatitis B. J Hepatol 38:S90-S103.
5. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002. 2003. Geneva, Switzerland. Consensus statement (short version). J Hepatol 38:533-540.
6. Fabrizi F, Bisegna S, Mangano S, Alongi G, Colucci P, Finazzi S, De Vecchi AF, Ponticelli C. 2002a. Hepatopathy and hepatitis B virus infection in dialysis patients: Cross-sectional study. G Ital Nefrol 19:149-154.
7. Fabrizi F, Lunghi G, Martin P, Poordad FF. 2002b. Serological and molecular testing in hepatitis B and the dialysis patient. Int J Artif Organs 25:91-99.
8. Fabrizi F, Lunghi G, Alongi G, Bisegna S, Campolo G, Mangano S, Limido A, Pagliari B, Tettamanzi F, Ponticelli C. 2003. Biological dynamics of hepatitis B virus load in dialysis population. Am J Kidney Dis 41:1278-1285.
9. Fattovich G. 2003. Natural history and prognosis of hepatitis B. Semin Liver Dis 23:47-58.
10. Gane E, Pilmore H. 2002. Management of chronic viral hepatitis before and after renal transplantation. Transplantation 74:427-437.
11. Girndt M, Kohler H. 2002. Hepatitis B virus infection in hemodialysis patients. Semin Nephrol 22:340-350.
12. Guh JY, Lai YH, Yang CY, Chen SC, Chuang WL, Hsu TC, Chen HC, Chang WY, Tsai JH. 1995. Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron 69:459-465.
13. Harnett JD, Parfrey PS, Kennedy M, Zeldis JB, Steinman TI, Guttmann RD. 1988. The long-term outcome of hepatitis B infection in hemodialysis patients. Am J Kidney Dis 11:210-213.
14. Josselson J, Kyser BA, Weir MR, Sadler JH. 1987. Hepatitis B surface antigenemia in a chronic hemodialysis program: Lack of influence on morbidity and mortality. Am J Kidney Dis 9:456-461.
15. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H, Wright TL. 2004. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. Clin Gastroenterol Hepatol 2:87-106.
16. Kroes AC, van Bommel EF, Niesters HG, Weimar W. 1994. Hepatitis B viral DNA detectable in dialysate. Nephron 67:369.
17. Liaw YF, Leung N, Guan R, Lau GK, Merican I. 2003. Asian-Pacific consensus statement on the management of chronic hepatitis B: An update. J Gastroenterol Hepatol 18:239-245.
18. Lin CL, Liao LY, Liu CJ, Chen PJ, Lai MY, Kao JH, Chen DS. 2002. Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B. J Gastroenterol 37:283-287.
19. Lindh M, Horal P, Dhillon AP, Furuta Y, Norkrans G. 1996. Hepatitis B virus carriers without precore mutations in hepatitis B e antigen-negative stage show more severe liver damage. Hepatology 24:494-501.
20. Locarnini S, McMillan J, Bartholomeusz A. 2003. The hepatitis B virus and common mutants. Semin Liver Dis 23:5-20.
21. Lok AS, McMahon BJ. 2001. Chronic hepatitis B. Hepatology 34:1225-1241.
22. London WT, Drew JS, Lustbader ED, Werner BG, Blumberg BS. 1977. Host responses to hepatitis B infection in patients in a chronic hemodialysis unit. Kidney Int 12:51-58.
23. Manesis EK, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ. 2003. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection. Am J Gastroenterol 98:2261-2267.
24. Marchesini G, Zoli M, Angiolini A, Feliciangeli G, Santoro A, Ferroni P, Zanetti AR. 1981. Relevance of HBe/anti-HBe system and DNA polymerase activity in chronic hepatitis-B virus carriers on haemodialysis. A prospective study. Nephron 29:44-48.
25. Mathurin P, Mouquet C, Poynard T, Sylla C, Benalia H, Fretz C, Thibault V, Cadranel JF, Bernard B, Opolon P, Coriat P, Bitker Mo. 1999. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 29:257-263.
26. Miller DJ, Williams AE, Le Bouvier GL, Dwyer JM, Grant J, Klatskin G. 1978. Hepatitis B in hemodialysis patients: significance of HBeAg. Gastroenterology 74:1208-1213.
27. Niitsuma H, Ishii M, Miura M, Kobayashi K, Toyota T. 1997. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers. Am J Gastroenterol 92:119-123.
28. Okamoto H, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M. 1990. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 64:1298-1303.
29. Pacheco MS, Palumbo MN, Tanaka TT, Perez RM, Matos CAL, Pace FHL, Lanzoni VP, Ferraz ML, Silva AE. 2000. The role of pre-core hepatitis B virus (HBV) nt.1896 mutant on acute and chronic hepatitis B in Sao Paulo, Brazil. Hepatology 32:465A.
30. Peng XM, Huang GM, Li JG, Huang YS, Mei YY, Gao ZL. 2005. High level of hepatitis B virus DNA after HBeAg-to-anti-HBe seroconversion is related to coexistence of mutations in its precore and basal core promoter. World J Gastroenterol 11:3131-3134.
31. Rezende RE, Fonseca BA, Ramalho LN, Zucoloto S, Pinho JR, Bertolini DA, Martinelli AL. 2005. The precore mutation is associated with severity of liver damage in Brazilian patients with chronic hepatitis B. J Clin Virol 32:53-59.
32. Salo RJ, Salo AA, Fahlberg WJ, Ellzey JT. 1980. Hepatitis B surface antigen (HBSAg) in peritoneal fluid of HBSAg carriers undergoing peritoneal dialysis. J Med Virol 6:29-35.
33. Sitnik R, Pinho JR, Bertolini DA, Bernardini AP, Da Silva LC, Carrilho /SNM> FJ. 2004. Hepatitis B virus genotypes and precore and core mutants in Brazilian patients. J Clin Microbiol 42:2455-2460.
34. Tanaka S, Yoshiba M, Iino S, Fukuda M, Nakao H, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M. 1995. A common-source outbreak of fulminant hepatitis B in hemodialysis patients induced by precore mutant. Kidney Int 48:1972-1978.
35. Teles SA, Martins RM, Silva SA, Gomes DM, Cardoso DD, Vanderborght BO, Yoshida CF. 1998. Hepatitis B virus infection profile in central Brazilian hemodialysis population. Rev Inst Med Trop Sao Paulo 40:281-286.
36. Teles SA, Martins RM, Gomes SA, Gaspar AM, Araujo NM, Souza KP, Carneiro MA, Yoshida CF. 2002. Hepatitis B virus transmission in Brazilian hemodialysis units: serological and molecular follow-up. J Med Virol 68:41-49.
37. Wong PN, Fung TT, Mak SK, Lo KY, Tong GM, Wong Y, Loo CK, Lam EK, Wong AK. 2005. Hepatitis B virus infection in dialysis patients. J Gastroenterol Hepatol 20:1641-1651.
38. Yasuda K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, Yokozeki K, Kobayashi S, Irie Y. 1995. Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterology 109:1295-1300.